Qifan Li
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Thromboembolism and Bleeding Risks in Atrial Fibrillation: Outcomes of Oral Anticoagulation After Catheter Ablation.
Journal: Journal of the American Heart Association
Published: August 31, 2026
Association of cognitive impairment with adverse cardiovascular outcomes: the mediating role of modifiable risk factors in a prospective cohort study.
Journal: BMJ open
Published: December 21, 2025
Catheter ablation is associated with reduced cardiovascular events in atrial fibrillation patients with atrial functional mitral regurgitation.
Journal: Heart rhythm
Published: October 06, 2025
Burden of Atrial Fibrillation and Atrial Flutter From 1990 to 2021 in China: Global Burden of Disease Study 2021 Update.
Journal: Pacing and clinical electrophysiology : PACE
Published: March 13, 2025
Pulmonary Vein Isolation With Optimized Linear Ablation vs Pulmonary Vein Isolation Alone for Persistent AF: The PROMPT-AF Randomized Clinical Trial.
Journal: JAMA
Published: November 18, 2024
Fibroblast growth factor 23 and outcomes of atrial fibrillation: from clinical association to genetic evidence.
Journal: European journal of preventive cardiology
Published: July 15, 2024
Characteristics of Right-Sided Accessory Pathways Associated With Right Cardiac Veins.
Journal: Circulation. Arrhythmia and electrophysiology
Published: May 01, 2024
Small Left Ventricle in Patients With Atrial Fibrillation Is Associated With Increased Cardiovascular Risk.
Journal: Journal of the American College of Cardiology
Published: February 16, 2024
Evaluation of an algorithm-guided photoplethysmography for atrial fibrillation burden using a smartwatch.
Journal: Pacing and clinical electrophysiology : PACE
Published: December 17, 2023
Systolic Blood Pressure Time in Target Range and Cognitive Outcomes: Insights From the SPRINT MIND Trial.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: May 11, 2023
Adalimumab for the treatment of cardiac sarcoidosis with multiple arrhythmias.
Journal: ESC heart failure
Published: May 27, 2022
Last Updated: 09/26/2026